Browse life science companies in London, including biotechnology firms, pharmaceutical companies and leading research organisations.
Nanotechnology drug delivery platform for precision medicines
Nanomerics is a UK speciality pharmaceutical company developing precision medicines using its proprietary technology, a polymer nanotechnology platform that improves the…
Breast milk microbiome biotech developing infant health solutions
BoobyBiome Ltd is a biotechnology company developing products to give formula-fed and high-risk infants access to the beneficial microbiome of breast milk. Its platform is built…
AI-powered immune profiling platform for precision medicine
IMU Biosciences is a biotechnology company coupling high-resolution, systems-level immune profiling with proprietary AI analytics to build a detailed atlas of the human immune…
Synthetic DNA, gene synthesis and NGS reagents for life science research
Twist Bioscience is a synthetic biology company offering a broad portfolio of DNA-based products and services for research, diagnostics, and therapeutic development. Its…
Full-service CRO specialising in oncology and early-phase trials
Pivotal CRO is a full-service contract research organisation providing end-to-end clinical development support across all trial phases, from first-in-human to Phase III. The…
RBC derived nanoparticles for RNA delivery to brain and immune cells
Crane Biosciences is a biotechnology company developing a non-immunogenic RNA delivery platform based on nanoparticles derived from red blood cell membranes. By using the body's…
AstraZeneca's rare disease arm targeting the complement cascade
Alexion, AstraZeneca Rare Disease is the rare disease group within AstraZeneca, formed following the 2021 acquisition of Alexion Pharmaceuticals. With nearly 30 years of rare…
UK learned society for pharmacology and medicines research
The British Pharmacological Society (BPS) is a UK membership charity dedicated to promoting and advancing all disciplines of pharmacology in the discovery, development, and use of…
Asymmetric biomaterial skin substitutes for acute and chronic wounds
Janus Biosciences is a biotech developing novel biomaterial skin substitutes for the treatment of acute and chronic wounds. The platform is based on asymmetric Janus material…
Clinical-stage peptide therapeutics for autoimmune and infectious disease
ImmuPharma is a clinical-stage biopharmaceutical company developing peptide-based therapeutics and precision diagnostics for autoimmune disease, infectious disease and metabolic…
Hypoxia-activated CAR-T cell therapy platform for solid tumour cancers
Korecyte Bio is a preclinical-stage cell therapy company developing HypoxiCAR, a modular CAR-T platform for treating solid tumours. The technology uses a dual-sensor genetic…
AI-driven target discovery from human tissue omics
Relation is a platform biotechnology company integrating machine learning with single-cell and spatial multi-omics data derived directly from patient tissue to discover and…